| | |
| Straumann to cut jobs as Europe sales slow Monday, Oct 29, 2012 11:58 PM PDT ZURICH (Reuters) - Swiss dental implant maker Straumann said it would axe roughly 150 jobs to boost margins as it grapples with sluggish demand in Europe. The dental implant market was hit hard by the financial crisis and has been further hamstrung by the euro zone debt crisis as cash-strapped Europeans, worried about the downturn, cut back on non-essential dental treatment. ... Full Story | Top |
| U.S. nuclear plant declares "alert" after Sandy storm surge: NRC Monday, Oct 29, 2012 11:55 PM PDT  NEW YORK (Reuters) - Exelon Corp declared an "alert" at its New Jersey Oyster Creek nuclear power plant due to a record storm surge, the Nuclear Regulatory Commission said, warning that a further water rise could force the country's oldest working plant to use emergency water supplies to cool spent uranium fuel rods. The alert -- the second lowest of four NRC action levels -- came after water levels at the plant rose by more than 6.5 feet, potentially affecting the pumps that circulate water through the plant, an NRC spokesman said late on Monday. ... Full Story | Top |
| Bayer says to acquire U.S. vitamin maker Schiff Monday, Oct 29, 2012 11:03 PM PDT FRANKFURT (Reuters) - Germany's Bayer plans to buy U.S. vitamins maker Schiff Nutrition International in an agreed $1.2 billion deal as it continues to focus on smaller acquisitions. "Bayer is committed to augment its organic growth with strategic bolt-on acquisitions. This transaction represents an excellent strategic fit for our HealthCare business," said Bayer Chief Executive Marijn Dekkers. Germany's largest drugmaker said on Tuesday it is offering $34 per share in cash to Schiff shareholders, a 47 percent premium over the Friday closing price of $23. ... Full Story | Top |
| Meningitis outbreak spreads to 19 states with case in Rhode Island Monday, Oct 29, 2012 06:04 PM PDT  (Reuters) - The deadly meningitis outbreak tied to steroid injections from potentially tainted medications spread to a 19th state on Monday with the first case reported in Rhode Island, the Centers for Disease Control and Prevention said. Only four of the 23 states that received some of the medication have not reported cases of fungal meningitis, which has killed 25 people nationwide. The four states that have not reported at least one case of meningitis are California, Nevada, West Virginia and Connecticut, the CDC said. ... Full Story | Top |
| Lilly trials boost amyloid link to Alzheimer's-analysis Monday, Oct 29, 2012 02:39 PM PDT (Reuters) - Levels of a protein believed to be a main cause of Alzheimer's disease rose in the blood of patients treated with Eli Lilly's experimental drug in late-stage trials, suggesting the protein, beta amyloid, was removed from the brain as intended, researchers said on Monday. Lilly in August disclosed that its drug solanezumab did not significantly arrest progression of the memory-robbing disease in the pair of Phase III studies, which tested patients with mild to moderate symptoms of Alzheimer's. ... Full Story | Top |
| Cancer docs often delay referrals to hospice care Monday, Oct 29, 2012 02:01 PM PDT  NEW YORK (Reuters Health) - Cancer doctors often refer their patients to palliative care very late in the course of disease, according to a new survey from Canada. About a third of oncologists said they refer patients to palliative care, or hospice, when they diagnose a cancer that has spread and therefore usually is incurable. Another third, however, said they wait until chemotherapy has been stopped, which is often just a few months or even weeks away from death. "All palliative specialists believe that palliative care should be involved early," said Dr. ... Full Story | Top |
| Acupuncture may ease cancer-related fatigue Monday, Oct 29, 2012 01:16 PM PDT NEW YORK (Reuters Health) - Acupuncture may help relieve fatigue in women who've had breast cancer, a new UK study suggests. Researchers found that women who attended six weekly acupuncture sessions had greater improvements in fatigue as well as anxiety, depression and quality of life, compared to those who only received educational materials. But that still doesn't prove it was the needles, themselves, that boosted women's energy levels, they said. ... Full Story | Top |
| Do secondhand smoke laws prevent heart attacks? Monday, Oct 29, 2012 01:14 PM PDT NEW YORK (Reuters Health) - Heart attacks dropped by one-third in one county in Minnesota after two smoke-free workplace ordinances went into place, a new study shows. The lead researcher on the work said that decline was likely due to less secondhand smoke exposure in restaurants and bars, as smoke can trigger heart problems due to its effects on arteries and blood clotting. ... Full Story | Top |
| Slimmer future for heavy kids who get help early Monday, Oct 29, 2012 01:13 PM PDT NEW YORK (Reuters Health) - Weight-loss programs can help even very young children slim down, and it appears that acting early may improve the odds of success, according to a pair of new studies. "What they are showing is a pretty consistent trend that if we were to intervene early, we could really have an effect on changing the trajectory of weight gain in children," said Dr. Elsie Taveras, a pediatrician at Harvard Medical School and Boston Children's Hospital, who co-wrote an editorial on the findings. ... Full Story | Top |
| French implant boss released from jail pending trial Monday, Oct 29, 2012 12:55 PM PDT MARSEILLE, France (Reuters) - The Frenchman who sparked a global health scare by selling substandard breast implants has been released from jail under court supervision pending a trial next year, a judicial source said on Friday. Jean-Claude Mas, who faces charges of causing involuntary bodily harm and aggravated fraud, spent eight months in prison after he failed to post bail. Mas, 73, was released from a penitentiary in southeastern France on condition that he remained within the Var and Bouches-du-Rhone regions and checked in once a week at the police station in his home town. ... Full Story | Top |
| Supreme Court won't hear case of Liberty Bell abortion protester Monday, Oct 29, 2012 11:16 AM PDT WASHINGTON (Reuters) - The Supreme Court on Monday refused to hear the appeal of an anti-abortion protester who claimed his free speech rights were violated when park rangers removed him from a sidewalk near the Liberty Bell in Philadelphia. Without comment, the court said it would not take up the case of Michael Marcavage, who was arrested in October 2007 when he used a bullhorn to lead a protest at the entrance to the Liberty Bell Center at Independence National Historical Park. ... Full Story | Top |
| Storm damages crops in Haiti, fueling food price woes Monday, Oct 29, 2012 10:53 AM PDT PORT-AU-PRINCE, Haiti (Reuters) - As Hurricane Sandy barreled toward the U.S. East Coast on Monday, the full extent of the storm's havoc on Haiti was just beginning to emerge. Extensive damage to crops throughout the southern third of the country, as well as the high potential for a spike in cases of cholera and other water-borne diseases, could mean Haiti will see the deadliest effects of Sandy in the coming days and weeks. Haiti reported the highest death toll in the Caribbean, as swollen rivers and landslides claimed at least 52 lives, according to the country's Civil Protection office. ... Full Story | Top |
| Florida health department suspends compounding pharmacy Monday, Oct 29, 2012 09:39 AM PDT (Reuters) - The Florida Department of Health has temporarily suspended compounding operations at a pharmacy, the latest in a growing number of closings since a deadly meningitis outbreak caused by contaminated drugs in a Massachusetts facility. The Florida pharmacy, based in Boca Raton and called Rejuvi Pharmaceuticals, prepares injectable drugs and medications. The Florida health department said in a statement that it violated "a number" of statutes and rules. Rejuvi Pharmaceuticals' website says it makes "bio identical hormones" and compounded medications. ... Full Story | Top |
| Bayer's regorafenib gets priority review by FDA Monday, Oct 29, 2012 09:25 AM PDT FRANKFURT (Reuters) - U.S. health regulators granted a priority review for Bayer's cancer drug regorafenib for the treatment of gastrointestinal stromal tumors, potentially speeding up the treatment's route to market. The U.S. Food and Drug Administration grants priority reviews to medicines that are considered potentially significant therapeutic advancements over existing therapies. A priority review takes six months rather than the usual 10 to 12-months. Onyx Pharmaceuticals is the U.S. marketing partner for regorafenib, which will be branded as Stivarga. (Reporting by Ludwig Burger) Full Story | Top |
| Women hoist kettlebells for strength and shapeliness Monday, Oct 29, 2012 06:37 AM PDT NEW YORK (Reuters) - Kettlebells, classically a training tool of Russian strongmen, has become a go-to group fitness workout for women in pursuit of strong and sexy bodies, according to fitness experts. Lorna Kleidman, a world champion in kettlebell competition, said a modern kettlebell workout effectively combines cardiovascular, resistance and range-of-motion training, all in one hour. "It's all in the swing," said Kleidman, who teaches kettlebell classes at the Fitness Cell Collective in New York City, where women constitute up to 70 percent of her students. ... Full Story | Top |
|
No comments:
Post a Comment